Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction
11:43am, Wednesday, 05'th Nov 2025
On Nov. 3rd, Wall Street rendered a swift and brutal verdict on Kimberly-Clark's NASDAQ: KMB transformative acquisition of Kenvue NYSE: KVUE. While Kenvue's shares climbed over 12%, Kimberly-Clark's s
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kenvue Inc. (NYSE: KVUE)
06:00pm, Tuesday, 04'th Nov 2025
NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholder
Watch These Stocks Falling 10% Or More
04:58pm, Tuesday, 04'th Nov 2025
Fiserv (FI) leads decliners with a 49% drop, driven by leadership turmoil, weak consumer spending, and a downgraded quant rating to 'Strong Sell.' Alexandria Real Estate (ARE) and Robert Half (RHI) su
Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue
02:26pm, Tuesday, 04'th Nov 2025
Consumer staples ETFs, usually the quiet corner of the market, are suddenly in the spotlight. The $48.7 billion acquisition of Kenvue Inc. (NYSE:KVUE) by Kimberly-Clark Corp (NASDAQ:KMB) has stirred r
21,714 Shares in Kenvue Inc. $KVUE Acquired by World Investment Advisors
04:31am, Tuesday, 04'th Nov 2025
World Investment Advisors acquired a new stake in Kenvue Inc. (NYSE: KVUE) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acqui
These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors?
03:23am, Tuesday, 04'th Nov 2025
Kimberly-Clark is merging with Kenvue. The deal brings together two companies with long histories of growing their dividends.
The CEO Behind Kimberly-Clark's $40 Billion Gamble on Tylenol Maker
10:00pm, Monday, 03'rd Nov 2025
Mike Hsu aims to stoke the consumer company's growth by veering into Kenvue's higher-margin but risky health products.
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale
Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'
06:40pm, Monday, 03'rd Nov 2025
Kimberly-Clark CEO Mike Hsu told CNBC's Jim Cramer that his company's acquisition of Tylenol maker Kenvue will create value for shareholders, even as the the pain reliever is scrutinized by the Trump
Kenvue's legal risks loom over planned acquisition by Kimberly-Clark
05:20pm, Monday, 03'rd Nov 2025
Kimberly-Clark said on Monday it plans to acquire Band-Aid maker Kenvue , even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based baby powder, raising qu
S&P 500 Gains & Losses Today: Amazon Stock Jumps After OpenAI Deal; Kimberly-Clark Acquires Kenvue
05:15pm, Monday, 03'rd Nov 2025
A linkup with an artificial intelligence player helped power shares of a top cloud-computing services company higher Monday, while an acquisition in the consumer goods space sent the two stocks on div
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.
04:58pm, Monday, 03'rd Nov 2025
NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Kenvue Inc. (NYSE: KVUE) and its board of directors concerning the proposed acquisition
KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama
04:01pm, Monday, 03'rd Nov 2025
It's been a tough few weeks for the consumer health company Kenvue, after President Trump publicly spread unproven claims about Tylenol, one of its core subsidiary brands. Today, though, it seems like
Why Tylenol maker stock is popping despite Trump's autism warning
02:36pm, Monday, 03'rd Nov 2025
Kenvue (NYSE: KVUE) shares surged Monday, climbing by double digits as investors cheered news that consumer goods giant Kimberly-Clark (NASDAQ: KMB) plans to acquire the Tylenol maker
KVUE Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Kenvue to Kimberly-Clark
01:30pm, Monday, 03'rd Nov 2025
MONSEY, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Kenvue Inc. (NYSE: KVUE) (“Kenvue”) to Kimberly-Clark purs
